The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immunoglobulin Products-Global Market Insights and Sales Trends 2024
Synopsis
Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen. These are made up of basic structural unit’s namely heavy chains and light chains. In mammals five different types of antibodies (IgA, IgD, IgE, IgG and IgM) are present which perform different role in response to the type of foreign antibody encountered. Occurrences of situations where people are born with low or no level of immunoglobulin, or with an immune system that does not function properly are very common. In such condition fighting with germs and other infections become extremely difficult. Therefore, immunoglobulin therapy plays an important role for compensating the insufficient quantity of immunoglobulin in the body.
The global Immunoglobulin Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immunoglobulin Products in various end use industries. The expanding demands from the CIDP, Immunodeficiency Diseases, ITP and Hypogammaglobulinemia, are propelling Immunoglobulin Products market. IG A, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IG G segment is estimated at % CAGR for the next seven-year period.
The recent approval of immunoglobulins to treat neuroimmunological disorders is a noteworthy factor that will impel the prospects for market growth until the end of the forecast period. Recently, immunoglobulin products were approved for the treatment of neuroimmunological disorders like multifocal motor neuropathy, Alzheimer's disease, and Guillain-Barré syndrome. Due to its widespread applicability, immunoglobulin products that are utilized for the treatment of neuroimmunological disorders are anticipated to contribute the largest proportion of revenue to the global immunoglobulin products market in the next few years. Immunoglobulin products used for the treatment of primary immunodeficiency disease (PID) and neuroimmunological disorders account for around 80% of the total market revenue.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunoglobulin Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunoglobulin Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunoglobulin Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunoglobulin Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunoglobulin Products covered in this report include China Biologic Products, Grifols, Biotest Pharmaceuticals, Bio Products Laboratory, Octapharma, CSL, Kedrion, Bharat Serums and Vaccines and Emergent Biosolutions, etc.
The global Immunoglobulin Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
China Biologic Products
Grifols
Biotest Pharmaceuticals
Bio Products Laboratory
Octapharma
CSL
Kedrion
Bharat Serums and Vaccines
Emergent Biosolutions
Global Immunoglobulin Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunoglobulin Products market, Segment by Type:
IG A
IG G
IG M
IG D
IG E
Global Immunoglobulin Products market, by Application
CIDP
Immunodeficiency Diseases
ITP
Hypogammaglobulinemia
Congenital AIDS
Multifocal Motor Neuropathy
CLL
Myasthenia Gravis
Kawasaki Disease
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immunoglobulin Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immunoglobulin Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen. These are made up of basic structural unit’s namely heavy chains and light chains. In mammals five different types of antibodies (IgA, IgD, IgE, IgG and IgM) are present which perform different role in response to the type of foreign antibody encountered. Occurrences of situations where people are born with low or no level of immunoglobulin, or with an immune system that does not function properly are very common. In such condition fighting with germs and other infections become extremely difficult. Therefore, immunoglobulin therapy plays an important role for compensating the insufficient quantity of immunoglobulin in the body.
The global Immunoglobulin Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Immunoglobulin Products in various end use industries. The expanding demands from the CIDP, Immunodeficiency Diseases, ITP and Hypogammaglobulinemia, are propelling Immunoglobulin Products market. IG A, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IG G segment is estimated at % CAGR for the next seven-year period.
The recent approval of immunoglobulins to treat neuroimmunological disorders is a noteworthy factor that will impel the prospects for market growth until the end of the forecast period. Recently, immunoglobulin products were approved for the treatment of neuroimmunological disorders like multifocal motor neuropathy, Alzheimer's disease, and Guillain-Barré syndrome. Due to its widespread applicability, immunoglobulin products that are utilized for the treatment of neuroimmunological disorders are anticipated to contribute the largest proportion of revenue to the global immunoglobulin products market in the next few years. Immunoglobulin products used for the treatment of primary immunodeficiency disease (PID) and neuroimmunological disorders account for around 80% of the total market revenue.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunoglobulin Products, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunoglobulin Products market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunoglobulin Products market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunoglobulin Products sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunoglobulin Products covered in this report include China Biologic Products, Grifols, Biotest Pharmaceuticals, Bio Products Laboratory, Octapharma, CSL, Kedrion, Bharat Serums and Vaccines and Emergent Biosolutions, etc.
The global Immunoglobulin Products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
China Biologic Products
Grifols
Biotest Pharmaceuticals
Bio Products Laboratory
Octapharma
CSL
Kedrion
Bharat Serums and Vaccines
Emergent Biosolutions
Global Immunoglobulin Products market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunoglobulin Products market, Segment by Type:
IG A
IG G
IG M
IG D
IG E
Global Immunoglobulin Products market, by Application
CIDP
Immunodeficiency Diseases
ITP
Hypogammaglobulinemia
Congenital AIDS
Multifocal Motor Neuropathy
CLL
Myasthenia Gravis
Kawasaki Disease
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Immunoglobulin Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Immunoglobulin Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Immunoglobulin Products Market Overview
1.1 Immunoglobulin Products Product Overview
1.2 Immunoglobulin Products Market Segment by Type
1.2.1 IG A
1.2.2 IG G
1.2.3 IG M
1.2.4 IG D
1.2.5 IG E
1.3 Global Immunoglobulin Products Market Size by Type
1.3.1 Global Immunoglobulin Products Market Size Overview by Type (2018-2029)
1.3.2 Global Immunoglobulin Products Historic Market Size Review by Type (2018-2023)
1.3.3 Global Immunoglobulin Products Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Immunoglobulin Products Sales Breakdown by Type (2018-2023)
1.4.2 Europe Immunoglobulin Products Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Immunoglobulin Products Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Immunoglobulin Products Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Immunoglobulin Products Sales Breakdown by Type (2018-2023)
2 Global Immunoglobulin Products Market Competition by Company
2.1 Global Top Players by Immunoglobulin Products Sales (2018-2023)
2.2 Global Top Players by Immunoglobulin Products Revenue (2018-2023)
2.3 Global Top Players by Immunoglobulin Products Price (2018-2023)
2.4 Global Top Manufacturers Immunoglobulin Products Manufacturing Base Distribution, Sales Area, Product Type
2.5 Immunoglobulin Products Market Competitive Situation and Trends
2.5.1 Immunoglobulin Products Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Immunoglobulin Products Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunoglobulin Products as of 2022)
2.7 Date of Key Manufacturers Enter into Immunoglobulin Products Market
2.8 Key Manufacturers Immunoglobulin Products Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Immunoglobulin Products Status and Outlook by Region
3.1 Global Immunoglobulin Products Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Immunoglobulin Products Historic Market Size by Region
3.2.1 Global Immunoglobulin Products Sales in Volume by Region (2018-2023)
3.2.2 Global Immunoglobulin Products Sales in Value by Region (2018-2023)
3.2.3 Global Immunoglobulin Products Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Immunoglobulin Products Forecasted Market Size by Region
3.3.1 Global Immunoglobulin Products Sales in Volume by Region (2024-2029)
3.3.2 Global Immunoglobulin Products Sales in Value by Region (2024-2029)
3.3.3 Global Immunoglobulin Products Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Immunoglobulin Products by Application
4.1 Immunoglobulin Products Market Segment by Application
4.1.1 CIDP
4.1.2 Immunodeficiency Diseases
4.1.3 ITP
4.1.4 Hypogammaglobulinemia
4.1.5 Congenital AIDS
4.1.6 Multifocal Motor Neuropathy
4.1.7 CLL
4.1.8 Myasthenia Gravis
4.1.9 Kawasaki Disease
4.2 Global Immunoglobulin Products Market Size by Application
4.2.1 Global Immunoglobulin Products Market Size Overview by Application (2018-2029)
4.2.2 Global Immunoglobulin Products Historic Market Size Review by Application (2018-2023)
4.2.3 Global Immunoglobulin Products Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Immunoglobulin Products Sales Breakdown by Application (2018-2023)
4.3.2 Europe Immunoglobulin Products Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Immunoglobulin Products Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Immunoglobulin Products Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Immunoglobulin Products Sales Breakdown by Application (2018-2023)
5 North America Immunoglobulin Products by Country
5.1 North America Immunoglobulin Products Historic Market Size by Country
5.1.1 North America Immunoglobulin Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Immunoglobulin Products Sales in Volume by Country (2018-2023)
5.1.3 North America Immunoglobulin Products Sales in Value by Country (2018-2023)
5.2 North America Immunoglobulin Products Forecasted Market Size by Country
5.2.1 North America Immunoglobulin Products Sales in Volume by Country (2024-2029)
5.2.2 North America Immunoglobulin Products Sales in Value by Country (2024-2029)
6 Europe Immunoglobulin Products by Country
6.1 Europe Immunoglobulin Products Historic Market Size by Country
6.1.1 Europe Immunoglobulin Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Immunoglobulin Products Sales in Volume by Country (2018-2023)
6.1.3 Europe Immunoglobulin Products Sales in Value by Country (2018-2023)
6.2 Europe Immunoglobulin Products Forecasted Market Size by Country
6.2.1 Europe Immunoglobulin Products Sales in Volume by Country (2024-2029)
6.2.2 Europe Immunoglobulin Products Sales in Value by Country (2024-2029)
7 Asia-Pacific Immunoglobulin Products by Region
7.1 Asia-Pacific Immunoglobulin Products Historic Market Size by Region
7.1.1 Asia-Pacific Immunoglobulin Products Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Immunoglobulin Products Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Immunoglobulin Products Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Immunoglobulin Products Forecasted Market Size by Region
7.2.1 Asia-Pacific Immunoglobulin Products Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Immunoglobulin Products Sales in Value by Region (2024-2029)
8 Latin America Immunoglobulin Products by Country
8.1 Latin America Immunoglobulin Products Historic Market Size by Country
8.1.1 Latin America Immunoglobulin Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Immunoglobulin Products Sales in Volume by Country (2018-2023)
8.1.3 Latin America Immunoglobulin Products Sales in Value by Country (2018-2023)
8.2 Latin America Immunoglobulin Products Forecasted Market Size by Country
8.2.1 Latin America Immunoglobulin Products Sales in Volume by Country (2024-2029)
8.2.2 Latin America Immunoglobulin Products Sales in Value by Country (2024-2029)
9 Middle East and Africa Immunoglobulin Products by Country
9.1 Middle East and Africa Immunoglobulin Products Historic Market Size by Country
9.1.1 Middle East and Africa Immunoglobulin Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Immunoglobulin Products Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Immunoglobulin Products Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Immunoglobulin Products Forecasted Market Size by Country
9.2.1 Middle East and Africa Immunoglobulin Products Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Immunoglobulin Products Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 China Biologic Products
10.1.1 China Biologic Products Company Information
10.1.2 China Biologic Products Introduction and Business Overview
10.1.3 China Biologic Products Immunoglobulin Products Sales, Revenue and Gross Margin (2018-2023)
10.1.4 China Biologic Products Immunoglobulin Products Products Offered
10.1.5 China Biologic Products Recent Development
10.2 Grifols
10.2.1 Grifols Company Information
10.2.2 Grifols Introduction and Business Overview
10.2.3 Grifols Immunoglobulin Products Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Grifols Immunoglobulin Products Products Offered
10.2.5 Grifols Recent Development
10.3 Biotest Pharmaceuticals
10.3.1 Biotest Pharmaceuticals Company Information
10.3.2 Biotest Pharmaceuticals Introduction and Business Overview
10.3.3 Biotest Pharmaceuticals Immunoglobulin Products Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Biotest Pharmaceuticals Immunoglobulin Products Products Offered
10.3.5 Biotest Pharmaceuticals Recent Development
10.4 Bio Products Laboratory
10.4.1 Bio Products Laboratory Company Information
10.4.2 Bio Products Laboratory Introduction and Business Overview
10.4.3 Bio Products Laboratory Immunoglobulin Products Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bio Products Laboratory Immunoglobulin Products Products Offered
10.4.5 Bio Products Laboratory Recent Development
10.5 Octapharma
10.5.1 Octapharma Company Information
10.5.2 Octapharma Introduction and Business Overview
10.5.3 Octapharma Immunoglobulin Products Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Octapharma Immunoglobulin Products Products Offered
10.5.5 Octapharma Recent Development
10.6 CSL
10.6.1 CSL Company Information
10.6.2 CSL Introduction and Business Overview
10.6.3 CSL Immunoglobulin Products Sales, Revenue and Gross Margin (2018-2023)
10.6.4 CSL Immunoglobulin Products Products Offered
10.6.5 CSL Recent Development
10.7 Kedrion
10.7.1 Kedrion Company Information
10.7.2 Kedrion Introduction and Business Overview
10.7.3 Kedrion Immunoglobulin Products Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Kedrion Immunoglobulin Products Products Offered
10.7.5 Kedrion Recent Development
10.8 Bharat Serums and Vaccines
10.8.1 Bharat Serums and Vaccines Company Information
10.8.2 Bharat Serums and Vaccines Introduction and Business Overview
10.8.3 Bharat Serums and Vaccines Immunoglobulin Products Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bharat Serums and Vaccines Immunoglobulin Products Products Offered
10.8.5 Bharat Serums and Vaccines Recent Development
10.9 Emergent Biosolutions
10.9.1 Emergent Biosolutions Company Information
10.9.2 Emergent Biosolutions Introduction and Business Overview
10.9.3 Emergent Biosolutions Immunoglobulin Products Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Emergent Biosolutions Immunoglobulin Products Products Offered
10.9.5 Emergent Biosolutions Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Immunoglobulin Products Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Immunoglobulin Products Industrial Chain Analysis
11.4 Immunoglobulin Products Market Dynamics
11.4.1 Immunoglobulin Products Industry Trends
11.4.2 Immunoglobulin Products Market Drivers
11.4.3 Immunoglobulin Products Market Challenges
11.4.4 Immunoglobulin Products Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Immunoglobulin Products Distributors
12.3 Immunoglobulin Products Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
